Trump Admin Ousts FDA Chief Marty Makary in Fourth High-Profile Shakeup
TL;DR Summary
Dr. Marty Makary is leaving as FDA commissioner, the fourth high-profile Trump-era departure this year; his tenure coincided with the FDA authorizing fruit-flavored vapes for adults and GOP pressure over a promised safety review of the abortion drug mifepristone, with reports that Makary asked officials to delay the review until after the midterms.
- Dr. Marty Makary is out as FDA commissioner NBC News
- F.D.A. Commissioner Marty Makary Resigns After Weeks of Pressure The New York Times
- FDA chief to depart after Trump signed off on ousting him CNN
- Trump FDA chief is leaving after angering pharma CEOs, vaping lobbyists and anti-abortion groups AP News
- FDA chief plans to resign amid agency turmoil The Washington Post
Reading Insights
Total Reads
0
Unique Readers
4
Time Saved
2 min
vs 3 min read
Condensed
87%
410 → 53 words
Want the full story? Read the original article
Read on NBC News